Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Cellanome, Inc — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Cellanome announced it raised $150 Million in an initial filing from an offering of $150 Million

PRIVATEJan 29, 2024•over 2 years ago

Amount Raised

$150 Million

Palo AltoBiotechnology

Company Information

Company

Cellanome, Inc

Location

1810 Embarcadero Rd, Suite 200

Palo Alto, California, United States

About

Cellanome is developing a unique multiomics platform to measure biology at an unprecedented resolution and scale. Central to this vision is our proprietary technology, as well as cutting edge synthetic biology and informatics methods.

Predictive Intelligence
Strategic

ML-powered predictions for Cellanome, Inc's next move

Learn about Strategic plan

Related People

Suggested for you
1 contact

Sign in to view contact details

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Cellanome, Inc? See every signal — funding, hires, M&A, contracts, sentiment.

See plans